Biotechnology atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Stockmarkets AI fails to detect depression signs in social media posts by Black Americans, study finds Reuters via biedexmarkets.com Read more
Biotechnology Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression – ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more
Biotechnology Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment – Compass Pathways (NASDAQ:CMPS) Read more
Biotechnology UBS Bullish On This Depression Drug Maker, Says Alzheimer’s Agitation Data Is Attractive Catalyst – Axsome Therapeutics (NASDAQ:AXSM) Read more